PDCD1 and neoplasm: Different thresholds have been used to define PD-1/PDL1 positivity, but cut-off points as the proportion of membrane-positive tumor cells were subjective in terms of estimated visual levels, such that reproducibility has not been formally assessed in the clinical setting.